Friedrich Sinner

机构：University Hospital Magdeburg, Otto-von-Guericke-Universität Magdeburg · ORCID：0000-0003-0524-8833

发表论文 37 篇 · 总被引 527 次 · h-index 7

代表论文

• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)
• Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events (2024 · JHEP Reports · 被引 18)
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab (2024 · JHEP Reports · 被引 10)
• Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study (2025 · Cancers · 被引 7)
• Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial (2024 · Cancers · 被引 6)
• Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 5)